Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies. [electronic resource]
- Rheumatology international May 2008
- 661-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't